Neurolief Presents Groundbreaking Study Results of its Proliv™Rx Brain Neuromodulation Therapy for Treating Major Depression at the 7th Annual Neuropsychiatric Drug Summit

Posted on by

A New Brain Neuromodulation Therapy Sparks High Interest from Major Pharma Executives TAMPA, Fla., Oct. 8, 2024 /PRNewswire/ — Neurolief, a leading pioneer in neuromodulation technology, recently unveiled its pivotal multicenter RCT clinical study results for its Proliv™Rx brain…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.